Stock analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE opened at $0.01 on Monday. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.42. The company has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.03.
Sorrento Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- Stock Splits, Do They Really Impact Investors?
- Micron Technology Stock Volatile Despite Analyst Upgrades
- What is Forex and How Does it Work?
- McDonald’s Stock: Balancing Value and Innovation
- What Investors Need to Know About Upcoming IPOs
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.